• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 抗体 2F5 的中和作用与其重链第三互补决定区疏水性之间的关系。

Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region.

机构信息

Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

J Virol. 2010 Mar;84(6):2955-62. doi: 10.1128/JVI.02257-09. Epub 2009 Dec 30.

DOI:10.1128/JVI.02257-09
PMID:20042512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2826063/
Abstract

The membrane-proximal external region (MPER) of the HIV-1 gp41 transmembrane glycoprotein is the target of the broadly neutralizing antibody 2F5. Prior studies have suggested a two-component mechanism for 2F5-mediated neutralization involving both structure-specific recognition of a gp41 protein epitope and nonspecific interaction with the viral lipid membrane. Here, we mutationally alter a hydrophobic patch on the third complementarity-determining region of the heavy chain (CDR H3) of the 2F5 antibody and assess the abilities of altered 2F5 variants to bind gp41 and to neutralize diverse strains of HIV-1. CDR H3 alterations had little effect on the affinity of 2F5 variants for a peptide corresponding to its gp41 epitope. In contrast, strong effects and a high degree of correlation (P < 0.0001) were found between virus neutralization and CDR H3 hydrophobicity, as defined by predicted free energies of transfer from water to a lipid bilayer interface or to octanol. The effect of CDR H3 hydrophobicity on neutralization was independent of isolate sensitivity to 2F5, and CDR H3 variants with tryptophan substitutions were able to neutralize HIV-1 approximately 10-fold more potently than unmodified 2F5. A threshold was observed for increased hydrophobicity of the 2F5 CDR H3 loop beyond which effects on 2F5-mediated neutralization leveled off. Together, the results provide a more complete understanding of the 2F5 mechanism of HIV-1 neutralization and indicate ways to enhance the potency of MPER-directed antibodies.

摘要

HIV-1 gp41 跨膜糖蛋白的膜近端外部区域 (MPER) 是广泛中和抗体 2F5 的靶标。先前的研究表明,2F5 介导的中和作用涉及两种机制,包括对 gp41 蛋白表位的结构特异性识别和与病毒脂质膜的非特异性相互作用。在这里,我们突变改变了 2F5 抗体重链的第三互补决定区(CDR H3)上的一个疏水区,并评估了改变的 2F5 变体结合 gp41 和中和多种 HIV-1 株的能力。CDR H3 改变对 2F5 变体与对应其 gp41 表位的肽的亲和力几乎没有影响。相比之下,在病毒中和与 CDR H3 疏水性之间发现了强烈的影响和高度相关性(P < 0.0001),CDR H3 疏水性由从水到脂质双层界面或辛醇的预测自由能转移来定义。CDR H3 疏水性对中和的影响独立于分离株对 2F5 的敏感性,并且具有色氨酸取代的 CDR H3 变体能够比未修饰的 2F5 更有效地中和 HIV-1 约 10 倍。观察到 2F5 CDR H3 环的疏水性增加超过某个阈值,超过该阈值后,对 2F5 介导的中和水平的影响趋于平稳。总之,这些结果提供了对 2F5 中和 HIV-1 机制的更全面理解,并表明了增强 MPER 导向抗体效力的方法。

相似文献

1
Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region.HIV-1 抗体 2F5 的中和作用与其重链第三互补决定区疏水性之间的关系。
J Virol. 2010 Mar;84(6):2955-62. doi: 10.1128/JVI.02257-09. Epub 2009 Dec 30.
2
Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.抗1型HIV抗体2F5与磷脂双层的相互作用及其与病毒中和机制的相关性。
AIDS Res Hum Retroviruses. 2011 Aug;27(8):863-76. doi: 10.1089/AID.2010.0265. Epub 2011 Jan 15.
3
Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.2F5 样抗体 m66 和 m66.6 对 HIV-1 中和作用的结构基础
J Virol. 2014 Mar;88(5):2426-41. doi: 10.1128/JVI.02837-13. Epub 2013 Dec 11.
4
Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41.针对 gp41 膜近端区域的抗体对 HIV-1 的中和作用机制。
J Virol. 2014 Jan;88(2):1249-58. doi: 10.1128/JVI.02664-13. Epub 2013 Nov 13.
5
Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding.抗 HIV-1 广泛中和抗体 2F5 的互补决定区 H3 顶端的消融消除了中和能力而不影响核心表位结合。
J Virol. 2010 May;84(9):4136-47. doi: 10.1128/JVI.02357-09. Epub 2010 Feb 10.
6
Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.结构导向的 HIV-1 广谱中和抗体 2F5 的改变揭示了其中和功能的新特性。
PLoS Pathog. 2012;8(7):e1002806. doi: 10.1371/journal.ppat.1002806. Epub 2012 Jul 19.
7
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.重链的长互补决定区3在广泛中和抗人类免疫缺陷病毒1型抗体2F5的活性中起重要作用。
J Virol. 2004 Mar;78(6):3155-61. doi: 10.1128/jvi.78.6.3155-3161.2004.
8
Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.抗HIV-1抗体4E10的中和与非中和形式结合表位的结构和热力学基础
J Virol. 2015 Dec;89(23):11975-89. doi: 10.1128/JVI.01793-15. Epub 2015 Sep 16.
9
Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.广谱中和单克隆抗体2F5识别HIV-1的结构细节:表位构象、抗原识别环的灵活性及阴离子结合位点
J Mol Biol. 2008 Dec 12;384(2):377-92. doi: 10.1016/j.jmb.2008.09.024. Epub 2008 Sep 18.
10
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.一个 gp41 MPER 特异性的骆驼 VH 结构域需要一个疏水性的 CDR3 用于中和但不是用于抗原识别。
PLoS Pathog. 2013 Mar;9(3):e1003202. doi: 10.1371/journal.ppat.1003202. Epub 2013 Mar 7.

引用本文的文献

1
Role of antibody heavy and light chain interface residues in affinity maturation of binding to HIV envelope glycoprotein.抗体重链和轻链界面残基在与HIV包膜糖蛋白结合亲和力成熟中的作用。
Mol Syst Des Eng. 2019 Aug 2;4(4):737-746. doi: 10.1039/c8me00080h. Epub 2019 Feb 8.
2
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site.抗体定向进化揭示了 HIV-1 融合肽位点增强中和的机制。
Nat Commun. 2023 Nov 21;14(1):7593. doi: 10.1038/s41467-023-42098-5.
3
Inadequate structural constraint on Fab approach rather than paratope elicitation limits HIV-1 MPER vaccine utility.Fab 进入的结构约束不足而非中和表位诱导限制了 HIV-1 MPER 疫苗的应用。
Nat Commun. 2023 Nov 8;14(1):7218. doi: 10.1038/s41467-023-42097-6.
4
Age-related changes in antigen-specific natural antibodies are influenced by sex.年龄相关的抗原特异性天然抗体变化受性别影响。
Front Immunol. 2023 Jan 12;13:1047297. doi: 10.3389/fimmu.2022.1047297. eCollection 2022.
5
Enhancing HIV-1 Neutralization by Increasing the Local Concentration of Membrane-Proximal External Region-Directed Broadly Neutralizing Antibodies.通过增加膜近端外部区域导向的广谱中和抗体的局部浓度来增强 HIV-1 中和作用。
J Virol. 2023 Jan 31;97(1):e0164722. doi: 10.1128/jvi.01647-22. Epub 2022 Dec 21.
6
Neutralizing Antibodies Targeting HIV-1 gp41.靶向 HIV-1 gp41 的中和抗体。
Viruses. 2020 Oct 23;12(11):1210. doi: 10.3390/v12111210.
7
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.MPER 特异性人源广谱中和抗体 LN01 广谱中和 HIV-1 的结构基础。
Cell Host Microbe. 2019 Nov 13;26(5):623-637.e8. doi: 10.1016/j.chom.2019.09.016. Epub 2019 Oct 22.
8
Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state.gp41 MPER 在与 HIV-1 包膜预融合状态相关的脂双层上的拓扑分析。
Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22556-22566. doi: 10.1073/pnas.1912427116. Epub 2019 Oct 17.
9
Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity.结构基础上的抗原簇 A 区的 gp120 ,引发有效的效应细胞活性。
Viruses. 2019 Jan 16;11(1):69. doi: 10.3390/v11010069.
10
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.基于表位的疫苗设计产生了靶向融合肽的抗体,这些抗体能够中和多种 HIV-1 毒株。
Nat Med. 2018 Jun;24(6):857-867. doi: 10.1038/s41591-018-0042-6. Epub 2018 Jun 4.

本文引用的文献

1
Role of HIV membrane in neutralization by two broadly neutralizing antibodies.HIV 膜在两种广泛中和抗体中和作用中的作用。
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20234-9. doi: 10.1073/pnas.0908713106. Epub 2009 Nov 11.
2
MPEx: a tool for exploring membrane proteins.MPEx:一种用于研究膜蛋白的工具。
Protein Sci. 2009 Dec;18(12):2624-8. doi: 10.1002/pro.256.
3
Structural constraints imposed by the conserved fusion peptide on the HIV-1 gp41 epitope recognized by the broadly neutralizing antibody 2F5.保守融合肽对被广泛中和抗体2F5识别的HIV-1 gp41表位施加的结构限制。
J Phys Chem B. 2009 Oct 15;113(41):13626-37. doi: 10.1021/jp905965h.
4
Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications.广谱中和抗人免疫缺陷病毒1型抗体2F5表位多特异性的晶体学定义:对疫苗设计的启示
J Virol. 2009 Nov;83(22):11862-75. doi: 10.1128/JVI.01604-09. Epub 2009 Sep 9.
5
Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.1型人类免疫缺陷病毒对有效靶向CD4附着位点的单克隆抗体B12产生抗性的机制。
J Virol. 2009 Nov;83(21):10892-907. doi: 10.1128/JVI.01142-09. Epub 2009 Aug 19.
6
Structure of the HIV-1 gp41 membrane-proximal ectodomain region in a putative prefusion conformation.处于假定融合前构象的HIV-1 gp41膜近端胞外域区域的结构
Biochemistry. 2009 Apr 7;48(13):2915-23. doi: 10.1021/bi802303b.
7
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.中和HIV-1的4E10、2F5和WR304单克隆抗体的脂质结合特性
Biochim Biophys Acta. 2009 Mar;1788(3):660-5. doi: 10.1016/j.bbamem.2008.11.015. Epub 2008 Dec 3.
8
Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.广谱中和单克隆抗体2F5识别HIV-1的结构细节:表位构象、抗原识别环的灵活性及阴离子结合位点
J Mol Biol. 2008 Dec 12;384(2):377-92. doi: 10.1016/j.jmb.2008.09.024. Epub 2008 Sep 18.
9
Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.分析来自慢性感染1型人类免疫缺陷病毒B和C亚型患者的大量血浆中中和抗体的特异性。
J Virol. 2008 Dec;82(23):11651-68. doi: 10.1128/JVI.01762-08. Epub 2008 Sep 24.
10
4E10 and 2F5 monoclonal antibodies: binding specificities to phospholipids, tolerance, and clinical safety issues.4E10和2F5单克隆抗体:对磷脂的结合特异性、耐受性及临床安全性问题
AIDS. 2008 Mar 12;22(5):649-51. doi: 10.1097/QAD.0b013e3282f51922.